Maryland pilots program to end cannabis lab shopping
State moves to restrict retailers from choosing testing facilities, addressing potential quality and compliance vulnerabilities.
FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0Maryland is piloting a program designed to eliminate "lab shopping"—the practice of retailers selecting testing facilities for their cannabis products—according to MMJDaily. The initiative suggests state regulators are concerned that allowing operators discretion in lab selection may create compliance risks or quality inconsistencies, a common issue in maturing cannabis markets where testing standards significantly affect product safety and market confidence.
The timing aligns with Maryland's ongoing regulatory refinements. The state currently operates only one licensed testing lab against 127 open retail locations, according to the latest license roster, which may constrain testing capacity and incentivize workarounds. Recent related coverage shows Maryland's market has faced structural headwinds—sales averaged roughly $105 million monthly through August 2026—and the state has grappled with lab and facility delays.
Watch whether the pilot program mandates centralized lab assignment or establishes rotating lab pools. Clarity on implementation will signal how aggressively Maryland intends to tighten testing oversight as the market matures.
Original report: MMJDaily ↗